27.70EUR-1.07%Mkt Cap: 522.76M $P/E: 14.731d ago
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers homeopathic medicines and homeopathic specialties; and other healthcare products, i…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/E
Cheaper
P/B
Cheaper
Div Yield
Lower
1M Perf
Avg
Indicators:|
Key Statistics
Company
Market Cap522.76M $
Enterprise Value470.76M $
Revenue (TTM)544.68M $
Gross Profit397.53M $
Net Income (TTM)35.48M $
Revenue/Share31.37 USD
Last Price27.70 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2.4K
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)14.73
P/E (Forward)13.01
PEG2.38
EV/EBITDA6.26
EV/Revenue0.86
P/S0.96
P/B1.22
EPS (TTM)1.88
EPS (Forward)2.13
52W Range
20.8560% of range32.25
52W High32.25 EUR
52W Low20.85 EUR
Profitability
Gross Margin72.98%
Oper. Margin11.60%
EBITDA Margin13.80%
Profit Margin6.51%
ROE8.31%
ROA5.42%
Growth
Revenue Growth-1.40%
Earnings Growth165.90%
Cash Flow & Leverage
Operating CF57.87M $
CapEx (TTM)25.57M $
FCF Margin10.59%
FCF Yield11.03%
Net Debt-52.02M $
Net Debt/EBITDA-0.69
Balance Sheet
Debt/Equity0.08
Current Ratio2.22
Quick Ratio1.43
Book Value/Sh22.62 EUR
Cash/Share4.569 EUR
Dividends
Fwd Div Rate1.350 EUR
Trail. Div Rate1.350 EUR
Div. Yield4.82%
5Y Avg Yield3.35%
Payout Ratio63.83%
Ex-Div DateJun 3, 2026
Pay Date—
Splits
Last Split4:1
Split DateJul 1, 2003
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.17.36M
Float3.50M
Insiders79.00%
Institutions5.20%
Technical
SMA 5027.57 (+0.5%)
SMA 20028.05 (-1.3%)
Beta0.23
S&P 52W Chg20.05%
Avg Vol (30d)2.09K
Avg Vol (10d)1.59K
Technical Indicators
RSI (14)49.6
MACD-0.0082
MACD Signal0.0375
MACD Hist.-0.0457
BB Upper28.83 EUR
BB Middle27.91 EUR
BB Lower27.00 EUR
BB Width6.58%
ATR (14)0.6011 EUR
Vol Ratio (20d)0.26x